Twice-daily vs. once-daily inpatient dithranol for psoriasis

Clinical and Experimental Dermatology

Volumn 27, Issue 8, 2002, Pages 695-699

  Kirkup, M E ^a   Sabroe, R A ^a   Kavanagh, G M ^a   Downs, A M R ^a   Sansom, J E ^a   De Berker, D A R ^a   Dunnill, M G S ^a   Kennedy, C T C ^a   Archer, Clive B ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DITHRANOL;

ADOLESCENT; ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NURSING; PASTE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SKIN IRRITATION; THICKNESS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHRALIN; ANTI-INFLAMMATORY AGENTS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TREATMENT OUTCOME;

EID: 0036454887     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.01106.x     Document Type: Article

References (17)

1. Ingram JT. The approach to psoriasis. Br Med J 1953; 2: 591-4.
2. Rogers S, Marks J, Shuster S et al. Comparison of photochemotherapy and dithranol in treatment of chronic plaque psoriasis. Lancet 1979; 1: 455-8.
3. Selim MM, Goldberg LH, Schaefer H et al. Penetration studies on topical anthralin. Br J Dermatol 1981; 105 (s20): 101-3.
4. Statham BN, Rowell NR. Short contact dithranol therapy-twice daily and high concentration regimes. Br J Dermatol 1985; 113: 245-6. (letter).
5. Rogers S. Measurement of plaque thickness and evaporative water loss in psoriasis with PUVA and dithranol treatment. Clin Exp Dermatol 1993; 18: 21-4.
6. Mclennan A, Hellier FF. Treatment time in psoriasis. Br J Dermatol 1961; 73: 439-44.
7. Fast K. Ingram's treatment of psoriasis. Acta Dermatol 1960; 40: 516.
8. Durham GA, Morgan JK. A 7 year follow-up study of ninety patients with psoriasis. 1974; Br J. Dermatol 91: 7-11.
9. Weigand DA, Everett MA. Clearing of resistant psoriasis with anthralin. Arch Dermatol 1967; 96: 554-9.
10. Ross JB, Guptill J. Treatment of psoriasis with Ingram anthralin paste regime. Can Med Assoc J 1982; 126: 496.
11. de Bersaques J. A retrospective study of the inpatient treatment of psoriasis with dithranol. Dermatologia 1987; 175: 64-8.
12. Youn JI, Kim BK, Suh DH. The effectiveness of modified Ingram therapy compared with severity of psoriasis. J Dermatol 1998; 25: 112-7.
13. Marsden JR, Coburn PR, Marks J et al. Measurement of the response of psoriasis to short-term application of dithranol. Br J Dermatol 1983; 109: 209-18.
14. Macdonald KJ, Marks J. Short-contact anthralin in the treatment of psoriasis: A study of different contact times. Br J Dermatol 1986; 114: 235-9.
15. Parslew R, Friedmann PS. The irritancy of anthralin is inhibited by repeat applications of a subirritant concentration. Br J Dermatol 1999; 141: 469-74.
16. Kammerau B, Zesch A, Scaefer A. Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment; in vivo investigation with four different types of pharmaceutical vehicles. J Invest Dermatol 1975; 64: 145-9.
17. Ashton RE, Andre P, Lowe NJ et al. Anthralin: Historical and current perspectives. 1983; J Am Acad Dermatol 9: 173-92.